🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents

Recruitingn/aAges 18 Years - anyAllJordan Collaborating Cardiology Group
NCT07039149 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a chart review of data on use of antiplatelet (AP) medications for acute coronary syndrome in the ER. Guidelines recommend giving aspirin in the ER and a second AP agent in the cath lab. What is the outcome when the 2 agents are given n the ER?

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult patients * Presenting with acute coronary syndrome (ST segment elevation myocardial infarction, non ST segment elevation myocardial infarction, and unstable angina). * Antiplatelet medication (s) prescribed during index admission to hospital. * Willingness of the patient to be called for follow up up to 1 year after index hospitalization. Exclusion Criteria: * Non cardiac chest pain. * No administration of antiplatelet agents during hospitalization. * Refusal of contact for follow up.
💊

What it tests

  • Not listed
📍

Where

2 sites
Jordan University Hospital
Amman, Jordan
Istishari Hospital
Amman, Jordan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy